Suppr超能文献

经导管二尖瓣介入治疗。

Transcatheter mitral valve intervention.

作者信息

Ganatra Rea, Smith Robert

机构信息

Internal Medicine Trainee Royal Brompton and Harefield Hospitals, Guy's and St. Thomas' NHS Foundation Trust, Hill End Road, Harefield, UB9 6JH.

Consultant Cardiologist Royal Brompton and Harefield Hospitals, Guy's and St. Thomas' NHS Foundation Trust, Hill End Road, Harefield, UB9 6JH.

出版信息

Br J Cardiol. 2021 Nov 30;28(4):51. doi: 10.5837/bjc.2021.051. eCollection 2021.

Abstract

Mitral regurgitation is a common valvular heart disorder increasing with age. Many patients are ineligible for mitral valve surgery due to their age and other comorbidities. Left untreated, patients develop severe disease with a poor prognosis. The development of lower risk percutaneous mitral valve interventions has helped meet the needs of this previously untreated patient group. This review explores the recent and more established developments that have expanded the armamentarium for transcatheter mitral valve intervention.

摘要

二尖瓣反流是一种常见的心脏瓣膜疾病,其发病率随年龄增长而增加。许多患者由于年龄和其他合并症而不符合二尖瓣手术的条件。如果不进行治疗,患者会发展为严重疾病,预后较差。低风险经皮二尖瓣介入治疗的发展有助于满足这一以前未得到治疗的患者群体的需求。本综述探讨了最近以及更为成熟的进展,这些进展扩大了经导管二尖瓣介入治疗的手段。

相似文献

1
Transcatheter mitral valve intervention.经导管二尖瓣介入治疗。
Br J Cardiol. 2021 Nov 30;28(4):51. doi: 10.5837/bjc.2021.051. eCollection 2021.
2
Current devices and interventions in mitral regurgitation.当前二尖瓣反流的治疗设备和介入手段。
Herz. 2021 Oct;46(5):419-428. doi: 10.1007/s00059-021-05055-w. Epub 2021 Aug 16.
8
Transcatheter Treatment of Valvular Heart Disease: A Review.经导管瓣膜病治疗:综述。
JAMA. 2021 Jun 22;325(24):2480-2494. doi: 10.1001/jama.2021.2133.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验